TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 12 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $17,487,000 | +2.5% | 17,400,000 | 0.0% | 0.20% | -21.8% |
| Q3 2020 | $17,060,000 | +0.2% | 17,400,000 | 0.0% | 0.26% | -23.2% |
| Q2 2020 | $17,024,000 | +5.1% | 17,400,000 | 0.0% | 0.34% | -21.8% |
| Q1 2020 | $16,191,000 | -2.4% | 17,400,000 | 0.0% | 0.44% | +41.6% |
| Q4 2019 | $16,581,000 | -1.0% | 17,400,000 | -5.4% | 0.31% | +2.3% |
| Q3 2019 | $16,752,000 | +73.5% | 18,400,000 | +75.2% | 0.30% | +69.1% |
| Q2 2019 | $9,653,000 | -0.8% | 10,500,000 | 0.0% | 0.18% | -10.1% |
| Q1 2019 | $9,733,000 | +78.8% | 10,500,000 | +75.0% | 0.20% | +46.7% |
| Q4 2018 | $5,445,000 | +44.8% | 6,000,000 | +50.0% | 0.14% | +154.7% |
| Q3 2018 | $3,761,000 | -42.3% | 4,000,000 | -42.9% | 0.05% | -41.1% |
| Q2 2018 | $6,523,000 | -19.6% | 7,000,000 | -23.9% | 0.09% | -25.6% |
| Q1 2018 | $8,109,000 | +14.9% | 9,200,000 | +15.0% | 0.12% | +39.1% |
| Q4 2017 | $7,060,000 | – | 8,000,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 70,783,000 | $69,363,000 | 6.27% |
| INCOME RESEARCH & MANAGEMENT | 14,978,000 | $14,536,000 | 5.17% |
| PIPER SANDLER & CO. | 5,000,000 | $4,852,000 | 3.63% |
| Western Asset Management Company, LLC | 42,946,000 | $42,102,000 | 3.46% |
| PenderFund Capital Management Ltd. | 4,000,000 | $5,225,000 | 1.45% |
| Bracebridge Capital, LLC | 5,500,000 | $5,335,000 | 0.85% |
| WESTWOOD HOLDINGS GROUP INC | 43,185,000 | $42,490,000 | 0.54% |
| CORBYN INVESTMENT MANAGEMENT INC/MD | 1,025,000 | $995,000 | 0.52% |
| LMR Partners LLP | 22,235,000 | $21,742,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,357,000 | 0.36% |